Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
AIV-001 by AiViva BioPharma for Basal Cell Carcinoma (Basal Cell Epithelioma): Likelihood of Approval
AIV-001 is under clinical development by AiViva BioPharma and currently in Phase II for Basal Cell Carcinoma (Basal Cell Epithelioma)....